AI support app for men with newly spread prostate cancer
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This study tests an AI-powered app that provides support and guidance to people recently diagnosed with prostate cancer that has spread. It aims to help manage anxiety and improve quality of life during this stressful time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have prostate cancer that has spread to other parts of the body (metastatic).
- You must have been diagnosed with this spread within the last 2 weeks.
- You must be between 18 and 80 years old.
- You must have at least mild anxiety symptoms (score of 5 or higher on a standard anxiety questionnaire).
- You need a smartphone and internet access to use the study's app or website.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a phone-based supportive care program for older men with prostate cancer. It aims to help with day-to-day management while you’re receiving hormone-related cancer treatment.
This study tests a digital support tool that helps you understand your prostate cancer diagnosis and treatment options. It uses artificial intelligence to guide you through educational materials and connect you with support resources.
This study tests whether mobile health apps can help prostate cancer patients manage their care. You will use an app for up to six months to track symptoms and get support, which may help you feel more in control.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study tests if a smartphone-based tracking system can help doctors decide when to change treatment for men with hormone-sensitive prostate cancer that has spread. It uses standard drugs (relugolix and an ARPI) and monitors PSA levels closely.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.